Detalles de la búsqueda
1.
Pharmacist-led patient education and adverse event management in patients with non-small cell lung cancer receiving afatinib in a community-based, real-world clinical setting.
J Oncol Pharm Pract
; 26(1): 13-22, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30832554
2.
Burden of chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer: A retrospective study from community oncology practices.
Cancer Med
; 12(8): 10020-10030, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37000119
3.
Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy.
Adv Ther
; 40(10): 4189-4215, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37490258
4.
Defining appropriate quality performance metrics for pharmacies dispensing oral oncology therapies.
Am J Manag Care
; 28(6 Spec No.): SP316-SP323, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36049229
5.
A call to action: oncology practices-and patients-need performance measures for managing oral therapies.
Am J Manag Care
; 28(6 Spec No.): SP324, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36049230
6.
New Enhancing Oncology Model builds on knowledge from the OCM.
Am J Manag Care
; 28(6 Spec No.): SP405-SP406, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36049232
7.
PBMs: their role, the problems, and how practices can work with PBMs.
Am J Manag Care
; 23(12 Spec No.): SP497-SP498, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29087662
Resultados
1 -
7
de 7
1
Próxima >
>>